The Intercept, Oct. 24, 2011
A dozen pharmaceutical companies have given doctors and other healthcare providers more than $760 million over the past two years – and those companies’ sales comprise 40 percent of the U.S. market.
The numbers come from the non-profit journalism organization Pro Publica, which assembled and continues to update a database on the payments. The payments, says Pro Publica, are for consulting, speaking, research and expenses on the part of the providers.
Drug companies have traditionally been very tight-lipped about those payments, Pro Publica notes, but, “Over the past two years, companies have begun posting this information on their websites, some as the result of legal settlements with the federal government.”
With bucks that big flying around, is the quality of care offered by providers accepting them compromised? “Absolutely,” said Dr. John Santa, head of the Consumer Reports Health Ratings Center.